Trade Summary

1 week ago, Sukhtian Ghiath M., serving as Dir at Outlook Therapeutics, Inc. (OTLK), purchased 8,539,709 shares at $0.59 per share, for a total transaction value of $4,999,999.62. Following this transaction, Sukhtian Ghiath M. now holds 22,092,068 shares of OTLK.

This purchase represents a 63.01% increase in Sukhtian Ghiath M.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, May 28, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 2, 2026 at 9:30 PM ET, 5 days after the trade was made.

Outlook Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.